Table 2.
Compd. No. | Dose [mg/kg] | % Protection against Edema | % Inhibition of Plasma PGE2 |
---|---|---|---|
5a | 2.5 | 31.76 ± 0.66 | 72.19 ± 0.45 |
5 | 40.05 ± 0.77 | 73.78 ± 0.43 | |
5b | 2.5 | 69.10 ± 0.85 | 82.65 ± 0.56 |
5 | 71.42 ± 0.96 | 84.25 ± 0.45 | |
5c | 2.5 | 78.65 ± 0.87 | 83.59 ± 0.68 |
5 | 88.96 ± 0.78 | 85.19 ± 0.79 | |
5d | 2.5 | 67.32 ± 0.89 | 83.13 ± 0.80 |
5 | 70.60 ± 0.90 | 84.72 ± 0.97 | |
5e | 2.5 | 92.88 ± 0.97 | 91.73 ± 0.53 |
5 | 97.15 ± 0.86 | 93.31 ± 0.46 | |
5f | 2.5 | 31.36 ± 0.55 | 61.28 ± 0.43 |
5 | 33.74 ± 0.64 | 62.84 ± 0.56 | |
5g | 2.5 | 41.82 ± 0.75 | 80.82 ± 0.44 |
5 | 44.21 ± 0.66 | 82.38 ± 0.21 | |
5h | 2.5 | 42.28 ± 0.57 | 75.49 ± 0.45 |
5 | 54.68 ± 0.75 | 77.13 ± 0.89 | |
5i | 2.5 | 40.45 ± 0.63 | 75.96 ± 0.96 |
5 | 42.80 ± 0.54 | 77.61 ± 0.89 | |
5j | 2.5 | 26.46 ± 0.45 | 66.45 ± 0.83 |
5 | 28.71 ± 0.56 | 68.11 ± 0.83 | |
5k | 2.5 | 19.99 ± 0.67 | 66.93 ± 0.83 |
5 | 22.34 ± 0.78 | 68.60 ± 0.98 | |
5l | 2.5 | 38.10 ± 0.69 | 75.01 ± 0.65 |
5 | 40.29 ± 0.77 | 76.65 ± 0.34 | |
Diclofenac sodium | 2.5 | 69.59 ± 0.44 | 55.49 ± 0.80 |
5 | 72.19 ± 0.54 | 70.59 ± 0.80 | |
Valdicoxib | 2.5 | 78.89 ± 0.33 | 60.09 ± 0.86 |
5 | 87.19 ± 0.23 | 81.11 ± 0.21 |
Values were calculated from the mean values of data from three separate experiments; All results are significant different from control values at p ≤ 0.005; All results are significant different from reference standard values at p ≤ 0.005.